Research
We are driving the next generation of discoveries to address critical cancer challenges and accelerate the translation of scientific evidence into patient benefit.
Education
Fostering an outstanding cancer care workforce to help maintain and enhance world-leading patient outcomes through online learning, courses and events.
Health Equity
Pursuing equity in access to cancer care and outcomes for all Victorians affected by cancer.
Consumer Engagement
Partnering with consumers at every step of our journey, because no-one knows cancer like someone who’s lived it.
About Us
Research, academic and clinical institutions working together to accelerate cancer research, knowledge and expertise to benefit all.
News & Events
The VCCC Alliance brings you the latest in cancer research, education and clinical care through engaging, relevant and informative events.

Chief Executive Officer

Required to support a culture within their organisation of responsible clinical trial practice and ensure their staff are aware of their responsibilities.

The governing body of a health service, local health district or local health network may include a Chief Executive Officer (CEO, also called Chief Executive, Executive Director, General Manager).  

The CEO role (or equivalent) is required to support a culture within their organisation of responsible clinical trial practice and ensure their staff are aware of their responsibilities. The position is responsible for ensuring all clinical trials undertaken within their organisation comply with the requirements of national and local legislation and ensures appropriate research governance, personnel, systems and structures are in place.

The CEO (or equivalent) is also responsible for:

  • Ensuring effective communication across the organisation with key individuals responsible for clinical trials
  • Monitoring clinical trials conducted within the health service organisation for compliance with policies and procedures
  • Delegating a person responsible for Site-Specific Assessment (SSA) and site authorisation and, an escalation process for disputed local site authorisation of clinical trials if required
  • Allocating sufficient resources for effective and efficient processing of ethical and scientific review by the Human Research Ethics Committee (HREC) and, SSA and site authorisation
  • Establishing systems for the management of complaints about clinical trials, including clinical trial research misconduct and fraud  
  • Allocating resources for education and training of HREC members and site-specific assessment personnel
  • Providing access to ongoing training and education that promotes and supports responsible clinical trial conduct for all members of clinical trial teams, researchers and those in other relevant roles such as staff in supporting departments
  • Ensuring supervisors of clinical trial research trainees have the appropriate skills, qualifications and resources
  • Providing access to facilities for the safe and secure storage and management of clinical trial data, records and primary materials and, where possible and appropriate, facilitate access for study personnel
  • Ensuring mechanisms are in place to collect and report on operational metrics and other agreed measures of operational performance to the governing body as required

Get the latest in cancer news, events and more, direct to your inbox

Join a network of Victorian cancer researchers, clinicians and consumers to keep your finger on the pulse.